InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Saturday, 12/07/2019 12:00:15 PM

Saturday, December 07, 2019 12:00:15 PM

Post# of 777
News: $SRRA Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting

Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting Canada NewsWire VANCOUVER, Dec. 7, 2019 - New analyses of Phase 3 data highlighting momelotinib's meaningful anemia benefit...

Read the whole news SRRA - Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting